About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD38.85
- USD39.91
- USD38.32
- USD62.58
- 13.50%
- 37M
- 793.60k
- 626.30k
- 2.1B
- 23.42
- -12.00%
Stock News
3 hours ago
These are America's 10 strongest state economies best prepared for a recession
CNBC
3 hours ago
A 38-year-old started his hummus business with a $450 blender. This year, it's set to bring in $50 million
CNBC
3 hours ago
How to handle an inheritance and build wealth — even when you think you’re ready
MarketWatch
4 hours ago
The Saturday Spread: Leveraging Applied Game Theory to Find Probabilistically Attractive Trades
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
